Angeli Landeros-Weisenberger, MD
she/her/hers, ella/la/suya
Associate Research Scientist; Co-chair Pediatric Protocol Review Committee, Yale Center for Clinical Investigation (YCCI); Member Human Investigation Committee 4-B, Yale HRPP
Research & Publications
Biography
News
Coauthors
Selected Publications
- Characterization of human basal ganglia organoidsBrady M, Mariani J, Koca Y, Szekely A, King R, Bloch M, Landeros-Weisenberger A, Leckman J, Vaccarino F. Characterization of human basal ganglia organoids. Molecular Psychiatry 2022, 27: 4823-4823. PMID: 36536052, DOI: 10.1038/s41380-022-01914-y.
- Comparative efficacy, tolerability, and acceptability of pharmacological interventions for the treatment of children, adolescents, and young adults with Tourette's syndrome: a systematic review and network meta-analysisFarhat L, Behling E, Landeros-Weisenberger A, Levine J, Macul Ferreira de Barros P, Wang Z, Bloch M. Comparative efficacy, tolerability, and acceptability of pharmacological interventions for the treatment of children, adolescents, and young adults with Tourette's syndrome: a systematic review and network meta-analysis. The Lancet Child & Adolescent Health 2022, 7: 112-126. PMID: 36528030, DOI: 10.1016/s2352-4642(22)00316-9.
- Mispatterning and interneuron deficit in Tourette Syndrome basal ganglia organoidsBrady M, Mariani J, Koca Y, Szekely A, King R, Bloch M, Landeros-Weisenberger A, Leckman J, Vaccarino F. Mispatterning and interneuron deficit in Tourette Syndrome basal ganglia organoids. Molecular Psychiatry 2022, 27: 5007-5019. PMID: 36447010, PMCID: PMC9949887, DOI: 10.1038/s41380-022-01880-5.
- Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled TrialDwyer J, Landeros-Weisenberger A, Johnson J, Londono Tobon A, Flores J, Nasir M, Couloures K, Sanacora G, Bloch M. Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial. FOCUS The Journal Of Lifelong Learning In Psychiatry 2022, 20: 241-251. PMID: 37153136, PMCID: PMC10153503, DOI: 10.1176/appi.focus.22020004.
- Comprehensive Assessment StrategiesKing R, Landeros-Weisenberger A. Comprehensive Assessment Strategies. 2022, 335-342. DOI: 10.1093/med/9780197543214.003.0020.
- Meta‐Analysis: Efficacy and Tolerability of Vesicular Monoamine Transporter Type 2 Inhibitors in the Treatment of Tic DisordersBehling E, Farhat LC, Landeros‐Weisenberger A, Bloch MH. Meta‐Analysis: Efficacy and Tolerability of Vesicular Monoamine Transporter Type 2 Inhibitors in the Treatment of Tic Disorders. Movement Disorders 2022, 37: 684-693. PMID: 35191552, DOI: 10.1002/mds.28957.
- Systematic Review and Meta-analysis: An Empirical Approach to Defining Treatment Response and Remission in Pediatric Obsessive-Compulsive DisorderFarhat LC, Vattimo EFQ, Ramakrishnan D, Levine JLS, Johnson JA, Artukoglu BB, Landeros-Weisenberger A, Asbahr FR, Cepeda SL, Comer JS, Fatori D, Franklin ME, Freeman JB, Geller DA, Grant PJ, Goodman WK, Heyman I, Ivarsson T, Lenhard F, Lewin AB, Li F, Merlo LJ, Mohsenabadi H, Peris TS, Piacentini J, Rosa-Alcázar AI, Rosa-Alcázar À, Rozenman M, Sapyta JJ, Serlachius E, Shabani MJ, Shavitt RG, Small BJ, Skarphedinsson G, Swedo SE, Thomsen PH, Turner C, Weidle B, Miguel EC, Storch EA, Mataix-Cols D, Bloch MH. Systematic Review and Meta-analysis: An Empirical Approach to Defining Treatment Response and Remission in Pediatric Obsessive-Compulsive Disorder. Journal Of The American Academy Of Child & Adolescent Psychiatry 2021, 61: 495-507. PMID: 34597773, DOI: 10.1016/j.jaac.2021.05.027.
- A Phase-2 Pilot Study of a Therapeutic Combination of Δ9-Tetrahydracannabinol and Palmitoylethanolamide for Adults With Tourette’s SyndromeBloch MH, Landeros-Weisenberger A, Johnson JA, Leckman JF. A Phase-2 Pilot Study of a Therapeutic Combination of Δ9-Tetrahydracannabinol and Palmitoylethanolamide for Adults With Tourette’s Syndrome. Journal Of Neuropsychiatry 2021, 33: 328-336. PMID: 34340527, DOI: 10.1176/appi.neuropsych.19080178.
- Correction to: Racial Implicit Associations in Psychiatric Diagnosis, Treatment, and Compliance ExpectationsLondono Tobon A, Flores JM, Taylor JH, Johnson I, Landeros-Weisenberger A, Aboiralor O, Avila-Quintero VJ, Bloch MH. Correction to: Racial Implicit Associations in Psychiatric Diagnosis, Treatment, and Compliance Expectations. Academic Psychiatry 2021, 45: 533-534. PMID: 33821450, DOI: 10.1007/s40596-021-01435-w.
- Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled TrialDwyer JB, Landeros-Weisenberger A, Johnson JA, Londono Tobon A, Flores JM, Nasir M, Couloures K, Sanacora G, Bloch MH. Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial. American Journal Of Psychiatry 2021, 178: 352-362. PMID: 33653121, DOI: 10.1176/appi.ajp.2020.20010018.
- 6.62 VALUE OF PARENT AND CLINICIAN RATINGS AND GENDER DIFFERENCES IN THE PREDICTABILITY OF RESPONSES TO INTEGRATED COMPUTER-PRESENTED AND PHYSICAL BRAIN-TRAINING EXERCISESVitulano L, Grantz H, Landeros-Weisenberger A, Katsovich L, Artukoglu B, Aktan S, Wang M, Geoffrion C, Vitulano M, Wexler B. 6.62 VALUE OF PARENT AND CLINICIAN RATINGS AND GENDER DIFFERENCES IN THE PREDICTABILITY OF RESPONSES TO INTEGRATED COMPUTER-PRESENTED AND PHYSICAL BRAIN-TRAINING EXERCISES. Journal Of The American Academy Of Child & Adolescent Psychiatry 2016, 55: s224. DOI: 10.1016/j.jaac.2016.09.381.
- Meta-Analysis of the Symptom Structure of Obsessive-Compulsive DisorderBloch M, Landeros-Weisenberger A, Rosario M, Pittenger C, Leckman J. Meta-Analysis of the Symptom Structure of Obsessive-Compulsive Disorder. FOCUS The Journal Of Lifelong Learning In Psychiatry 2015, 13: 232-243. DOI: 10.1176/appi.focus.130209.
- Comprehensive Assessment StrategiesKing R, Landeros-Weisenberger A. Comprehensive Assessment Strategies. 2013, 402-410. DOI: 10.1093/med/9780199796267.003.0018.
- LONG‐TERM OUTCOME IN ADULTS WITH OBSESSIVE‐COMPULSIVE DISORDERBloch MH, Green C, Kichuk SA, Dombrowski PA, Wasylink S, Billingslea E, Landeros‐Weisenberger A, Kelmendi B, Goodman WK, Leckman JF, Coric V, Pittenger C. LONG‐TERM OUTCOME IN ADULTS WITH OBSESSIVE‐COMPULSIVE DISORDER. Depression And Anxiety 2013, 30: 716-722. PMID: 23532944, PMCID: PMC3932438, DOI: 10.1002/da.22103.
- Interface Between Autism Spectrum Disorders and Obsessive-Compulsive Behaviors: A Genetic and Developmental PerspectiveJacob S, Landeros-Weisenberger A, Leckman J. Interface Between Autism Spectrum Disorders and Obsessive-Compulsive Behaviors: A Genetic and Developmental Perspective. 2011, 285-303. DOI: 10.1093/med/9780195371826.003.0020.
- Poor fine‐motor and visuospatial skills predict persistence of pediatric‐onset obsessive‐compulsive disorder into adulthoodBloch MH, Sukhodolsky DG, Dombrowski PA, Panza KE, Craiglow BG, Landeros‐Weisenberger A, Leckman JF, Peterson BS, Schultz RT. Poor fine‐motor and visuospatial skills predict persistence of pediatric‐onset obsessive‐compulsive disorder into adulthood. Journal Of Child Psychology And Psychiatry 2011, 52: 974-983. PMID: 21244423, PMCID: PMC3625937, DOI: 10.1111/j.1469-7610.2010.02366.x.
- Autism spectrum and obsessive–compulsive disorders: OC behaviors, phenotypes and geneticsJacob S, Landeros‐Weisenberger A, Leckman JF. Autism spectrum and obsessive–compulsive disorders: OC behaviors, phenotypes and genetics. Autism Research 2009, 2: 293-311. PMID: 20029829, PMCID: PMC3974607, DOI: 10.1002/aur.108.
- Association of the serotonin transporter polymorphism and obsessive‐compulsive disorder: Systematic reviewBloch MH, Landeros‐Weisenberger A, Sen S, Dombrowski P, Kelmendi B, Coric V, Pittenger C, Leckman JF. Association of the serotonin transporter polymorphism and obsessive‐compulsive disorder: Systematic review. American Journal Of Medical Genetics Part B Neuropsychiatric Genetics 2008, 147B: 850-858. PMID: 18186076, DOI: 10.1002/ajmg.b.30699.
- Response to Chamberlain et al. Re: Systematic Review: Pharmacological and Behavioral Treatments for TrichotillomaniaBloch M, Landeros-Weisenberger A, Dombrowski P, Nudel J, Pittenger C, Leckman J, Kelmendi B, Wegner R, Coric V. Response to Chamberlain et al. Re: Systematic Review: Pharmacological and Behavioral Treatments for Trichotillomania. Biological Psychiatry 2008, 63: e34-e35. DOI: 10.1016/j.biopsych.2008.01.022.
- Child and Adolescent Psychiatry: The Essentials KeithChengKathleen M.MyersChild and Adolescent Psychiatry: The Essentials2005Lippincott Williams & WilkinsPhiladelphia416$74.95 (hardcover).Landeros-Weisenberger A. Child and Adolescent Psychiatry: The Essentials KeithChengKathleen M.MyersChild and Adolescent Psychiatry: The Essentials2005Lippincott Williams & WilkinsPhiladelphia416$74.95 (hardcover). Journal Of The American Academy Of Child & Adolescent Psychiatry 2006, 45: 1146. DOI: 10.1097/01.chi.0000235081.55532.a5.
- Erratum: A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorderBloch M, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken M, Leckman J. Erratum: A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Molecular Psychiatry 2006, 11: 795-795. DOI: 10.1038/sj.mp.4001859.
Clinical Trials
| Conditions | Study Title |
|---|---|
| Diseases of the Nervous System; Genetics - Adult; Genetics - Pediatric; Mental Health & Behavioral Research | Brain Emotion Circuitry-Targeted Self-Monitoring and Regulation Therapy (BE-SMART) |
| Diseases of the Nervous System | PET and MRI in OCD and/or Tic disorders |